Searched for
DIAGNOSTICS AND PATHOLOGY SERVICES
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 27%, according to analystsWe are in a phase in the US-Israel-Iran war where statements are made, then retracted. And, in a matter of just 48 hours, they are made all...- Q-Line Biotec shares to list today. Check GMP ahead of debutQ-Line Biotech is poised for a strong stock market debut on Friday. Investor demand appears robust, with grey market trends showing a signi...
- Health services, medical education expansion to be driven by modern tech: Yogi AdityanathUttar Pradesh Chief Minister Yogi Adityanath reviewed health and medical education. He stressed improving treatment quality and expanding s...
- Vikas Khemani-backed Q-Line Biotech IPO subscribed over 2 times on Day 1 as GMP soars to 42%Vikas Khemani-backed Q-Line Biotech's IPO opened on Wednesday, aiming to raise up to Rs 214.48 crore on NSE Emerge. The company, operating ...
- Open to 4-5 acquisitions, but at sensible valuations: Ameera Shah, promoter and executive chairperson, Metropolis HealthcareMetropolis Healthcare is set for its next growth phase. The diagnostic chain will focus on genomics and specialty diagnostics. Strategic ac...
- New senior citizen bank account with doorstep banking and healthcare benefits launched by Bank of Baroda; Know the detailsBank of Baroda has introduced a new premium savings account for senior citizens. The 'bob Senior Citizen Vishesh Samman' account offers hea...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%It is tough to think positively about the markets when all the news is about blockades, wars, and everything that can disturb the global ec...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsIf you are putting fresh money into the stock market (or even looking to rejig your existing portfolio), it would be best not to react to w...
- Invicta Diagnostic raises Rs 6 crore in pre-IPO roundMumbai-based Invicta Diagnostic on Thursday said it has raised Rs 6 crore from marquee investors in its pre-IPO funding round.
- Neuberg, Star Imaging in joint venture to expand integrated diagnostics across MaharashtraNeuberg Diagnostics and Star Imaging have partnered to expand integrated diagnostic centers across Maharashtra, aiming to unify radiology, ...
- Will they outperform bearish and volatile markets? 5 stocks from diagnostics sector with an upside potential of up to 34%Two weeks back, there was a sudden uptick in diagnostic stocks. Reason: Talk of the human metapneumovirus, or HMPV, becoming another health...
- Is valuation readjustment over? Time to look at them again? 4 stocks from the diagnostics sector with upside potential of 11 to 25%In terms of stock prices, companies in the diagnostics sector have been big underperformers in three out of the past four years. In busines...
- Do lower expectations of analysts indicate an end of exile? 5 stocks from diagnostics sector with upside potential of up to 16%From being the top picks of a star portfolio manager, to the admission that he made a mistake with one of them – diagnostic stocks have bee...
- Are they making a quiet comeback? 4 stocks from diagnostics sector with upside potential of up to 35%From being one of the most sought after sectors during 2020 to 2021 and trading at extremely high valuations, diagnostic stocks have been u...
- Price wars are still on but... 4 stocks from diagnostics sector have upside potential of up to 26%In the last five years, the diagnostic segment of the healthcare sector has seen many ups and downs. During Covid, diagnostic players were ...
- Krsnaa Diagnostics plans 600 testing centres by end of FY24Krsnaa is banking on the B2C (business-to-customer) model, besides bidding for more PPP contracts to double revenue growth and triple profi...
- Krsnaa Diagnostics lists at 7% premium over issue priceThe IPO was subscribed on the first day itself. Overall, the issue received bids for 45,80,08,245 shares, which was 64.40 times the issue s...
- Sequoia to invest Rs 40 crore in Suburban DiagnosticsVenture fund Sequoia Capital has invested Rs 40 crore in pathology services provider Suburban Diagnostics in a deal that underscores rising...
- Medizinisch Diagnostiche Institute to invest Rs 50 cr in Indian armLargest German clinical laboratory, the Medizinisch Diagnostiche Institute (MDI), proposes to invest Rs 50 crore in its Indian subsidiary.
- Sequoia to sell around 15% in PathLabsSequoia Capital has put a part of its 30% stake in one of the country’s largest diagnostics and pathology services chain, Dr Lal PathLabs, ...
Load More
